Il Dong Pharmaceutical Co Ltd (249420) - Total Liabilities

Latest as of September 2025: ₩347.04 Billion KRW ≈ $235.18 Million USD

Based on the latest financial reports, Il Dong Pharmaceutical Co Ltd (249420) has total liabilities worth ₩347.04 Billion KRW (≈ $235.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Il Dong Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Il Dong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 249420 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Il Dong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Il Dong Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zhangjiagang Zhonghuan Hailu High-End Equipment Co. Ltd. SHE:301040	China	CN¥686.37 Million
Taimide Tech Inc TW:3645	Taiwan	NT$1.82 Billion
Greene County Bancorp Inc NASDAQ:GCBC	USA	$2.91 Billion
Fondul Proprietatea SA RO:FP	Romania	RON216.26 Million
First Bank NASDAQ:FRBA	USA	$3.52 Billion
Benz Mining Corp F:1VU	Germany	€4.71 Million
Regal Partners Global Investments Limited AU:RG1	Australia	AU$148.37 Million
Weave Communications Inc NYSE:WEAV	USA	$127.85 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Il Dong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 249420 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Il Dong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Il Dong Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Il Dong Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩429.99 Billion ≈ $291.39 Million	-1.60%
2023-12-31	₩437.00 Billion ≈ $296.15 Million	-4.50%
2022-12-31	₩457.59 Billion ≈ $310.10 Million	-16.56%
2021-12-31	₩548.39 Billion ≈ $371.63 Million	+56.36%
2020-12-31	₩350.73 Billion ≈ $237.68 Million	-2.53%
2019-12-31	₩359.83 Billion ≈ $243.85 Million	+25.01%
2018-12-31	₩287.84 Billion ≈ $195.07 Million	+2.97%
2017-12-31	₩279.55 Billion ≈ $189.45 Million	-0.85%
2016-12-31	₩281.94 Billion ≈ $191.07 Million	--

About Il Dong Pharmaceutical Co Ltd

KO:249420 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$406.13 Million

₩599.28 Billion KRW

Market Cap Rank

#13463 Global

#416 in Korea

Share Price

₩19020.00

Change (1 day)

-4.13%

52-Week Range

₩12530.00 - ₩44300.00

All Time High

₩75500.00